Impact of a Novel Prognostic Model, Hematopoietic Cell Transplant -Composite Risk (HCT-CR), on Allogeneic Transplant Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic syndrome

Outcomes after allogeneic stem-cell transplantion (AHSCT) are influenced by both disease and patient related factors. Here we developed a novel prognostic model, Hematopoietic Cell Transplant -Composite Risk (HCT-CR), by combining the refined disease risk index (DRI-R) and hematopoietic stem-cell tr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Bone Marrow Transplant
Autors principals: Kongtim, Piyanuch, Parmar, Simrit, Milton, Denái R., Ramos Perez, Jorge Miguel, Rondon, Gabriela, Chen, Julianne, Chilkulwar, Abhishek R., Al-Atrash, Gheath, Alousi, Amin, Andersson, Borje S., Im, Jin S., Hosing, Chitra M., Bashir, Qaiser, Khouri, Issa, Kebriaei, Partow, Oran, Betul, Popat, Uday, Champlin, Richard, Ciurea, Stefan O.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7285649/
https://ncbi.nlm.nih.gov/pubmed/30258129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-018-0344-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars